cGxP.wire https://validator.w3.org/feed/docs/rss2.html Delphi Diagnostics Validates EAI for Paclitaxel Benefit Hamlet BioPharma Advances Alpha1H into Phase 3 Trial Draeger Receives FDA Clearance for Evita V800 Upgrade Phanes Completes Phase 2 Enrollment for Spevatamig in PDAC Hamlet BioPharma Expands Alpha1H Trial for Bladder Cancer Lys Therapeutics Advances LYS241 with €25M Funding Boost Genprex Strengthens REQORSA Cancer Gene Therapy Patent Pierre Fabre Secures EU Approval for BRAFTOVI in mCRC US WorldMeds Secures Full FDA Approval for TECELRA REGENXBIO Advances NAVSUNLI Toward Accelerated Approval AbbVie to Acquire Apogee in $10.9B Immunology Expansion Murj Expands Cardiac Care Platform Across Australia and NZ MoonLake Reports Strong Phase 3 Sonelokimab HS Results BioArctic, Lilly Partner on Next-Gen Brain Therapies Insilico Medicine and SK Bio Launch $2.5B CNS Alliance CureGene Doses First Patient in Pivotal Evategrel Trial Antengene Signs Up to $1.9 Billion TCE Licensing Deal INTCO Medical Unveils Advanced Healthcare Solutions at WHX 2026 5W AI Index Reveals New Pharma Visibility Leaders Online Velico Reports Positive Trial Results for FrontlineODP Kyowa Hakko Presents New Evidence Supporting Cognizin’s Cognitive Benefits Mighty Therapeutics Announces New Era in Mitochondrial Medicine Avance Clinical Highlights Oncology Expertise at ASCO 2026 Novocure Reports Phase 3 TRIDENT Trial Results MediThinQ Partners With Synovis to Advance Digital Microsurgery Fapon Biopharma Showcases Dual B-Cell Immunotherapy Platform SOPHiA GENETICS Raises $57.5 Million to Accelerate AI Healthcare Terumo Blood and Cell Technologies Supports New Imara Sickle Cell Framework Belay Announces NCCN Recommendation for CSF-Based Profiling in High-Grade Gliomas CareDx Publishes New KOAR Kidney Transplant Data iQure Pharma Wins MJFF Grant for Parkinson’s Research cAMPfield Launches With $180M to Advance Oral IBD Therapy LOTTE Biologics Completes Songdo Plant 1 Construction CareDx Highlights Transplant Data at ATC 2026 PleoPharma Launches Phase 3 Trial for Cannabis Withdrawal Cambrian Bio Reports Positive Phase 1b ATX-304 Data New Gates Foundation Grant Fuels Replicate’s Fight Against Tuberculosis Takeda Deploys Boltz AI Models to Accelerate Drug Discovery Merz Therapeutics and Teijin Secure Japan Approval for XEOMIN® Voro and Alloy Partner on Next-Gen T-Cell Cancer Therapies Incyte Secures Japan Approval for Minjuvi in DLBCL Care Kither Biotech Completes Phase 1 Trial of KIT2014 NIH Study Reveals Brain Cells Driving Human Speech Activity CervoMed Secures $10 Million to Advance Brain Disease Pipeline Sanofi Wins Japan Approval for Sarclisa SC in Myeloma uniQure Reports Early AMT-260 Epilepsy Trial Results Channel Robotics Raises $4.6M for Endoscopic Robotics NYU Langone Performs First HIV-to-HIV Lung Transplant Telos Biotech and Made Scientific Partner to Advance TELOVANCE™ Evaluation Braeburn Presents New BRIXADI Data at CPDD 2026